Antioxidant and metabolic impairment result in DNA damage in arsenic-exposed individuals with severe dermatological manifestations in Eastern India

Environmental Toxicology

Volumn 27, Issue 6, 2012, Pages 342-350

  Maiti, Smarajit ^a   Chattopadhyay, Sandip ^a   Deb, Bimal ^a   Samanta, Tanmoy ^a   Maji, Gurupada ^a   Pan, Bappaditya ^a   Ghosh, Amar ^a   Ghosh, Debidas ^a  

^a VIDYASAGAR UNIVERSITY   (India)

Author keywords

Antioxidant systems; Arsenic in drinking water; Cancer; DNA fragmentation; Human metabolic profile; Skin lesions

Indexed keywords

ANTIOXIDANT SYSTEMS; CANCER; DNA FRAGMENTATION; METABOLIC PROFILES; SKIN LESION;

ALDEHYDES; AMINO ACIDS; BODY FLUIDS; DNA; FREE RADICALS; METABOLISM;

ARSENIC;

ALANINE AMINOTRANSFERASE; AMYLASE; ARSENIC; ASPARTATE AMINOTRANSFERASE; CATALASE; FREE RADICAL; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; THIOL; URIC ACID;

ANTIOXIDANT; APOPTOSIS; ARSENIC; BLOOD; GENOTOXICITY; IMMUNE SYSTEM; LESION; MENS HEALTH; METABOLISM; MUTAGENICITY; POLLUTION EXPOSURE; SKIN DISORDER; SYMPTOM; VILLAGE; WOMENS HEALTH;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; EOSINOPHIL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; LEUKOCYTE; LIPID PEROXIDATION; LYMPHOCYTE COUNT; MALE; METABOLIC DISORDER; MONOCYTE; MUTAGENESIS; NEUTROPHIL COUNT; PALMOPLANTAR KERATODERMA; PIGMENTATION; PRIORITY JOURNAL; SKIN DISEASE;

ANTIOXIDANTS; ARSENIC; ARSENIC POISONING; DNA DAMAGE; DRINKING WATER; FEMALE; HUMANS; INDIA; MALE; METABOLIC NETWORKS AND PATHWAYS; SKIN DISEASES; WATER POLLUTANTS, CHEMICAL;

INDIA;

EID: 84860639686     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20647     Document Type: Article

References (67)

1. Aebi H. Catalase in vitro. 1984. Methods Enzymol 105: 121-126.
2. Aposhian HV, Zakharyan RA, Avram MD, Kopplin MJ, Wollenberg ML. 2003. Oxidation and detoxification of trivalent arsenic species. Toxicol Appl Pharmacol 193: 1-8.
3. Avani G, Rao MV. 2007. Genotoxic effects in human lymphocytes exposed to arsenic and vitamin A. Toxicol In Vitro 21: 626-631.
4. Bergmeyer HU, Hørder M, Rej R. 1986. International Federation of Clinical Chemistry (IFCC) Scientific Committee. Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1). J Clin Chem Clin Biochem 24: 497-510.
5. Biswas R, Ghosh P, Banerjee N, Das JK, Sau T, Banerjee A, Roy S, Ganguly S, Chatterjee M, Mukherjee A, Giri AK. 2008. Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic. Hum Exp Toxicol 27: 381-386.
6. Bode AM, Dong Z. 2002. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol 42: 5-24.
7. Bouman A, Heineman MJ, Faas MM. 2005. Sex hormones and the immune response in humans. Hum Reprod Update 11: 411-423.
8. Bustamante J, Nutt L, Orrenius S, Gogvadze V. 2005. Arsenic stimulates release of cytochrome c from isolated mitochondria via induction of mitochondrial permeability transition. Toxicol Appl Pharmacol 207: 110-116.
9. Chakraborti D. Report of School of Environmental Studies, Jadavpur University, Calcutta. Available at:
10. Chakraborti D, Das B, Rahman MM, Chowdhury UK, Biswas B, Goswami AB, Nayak B, Pal A, Sengupta MK, Ahamed S, Hossain A, Basu G, Roychowdhury T, Das D. 2009. Status of groundwater arsenic contamination in the state of West Bengal. India: A 20-year study report. Mol Nutr Food Res 53: 542-551.
11. Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, Graziano JH, Ahsan H. 2009. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol 239: 184-192.
12. Copeland WH, Nealon DA, Rej R. 1985. Effects of temperature on measurement of alkaline phosphatase activity. Clin Chem 31: 185-190.
13. Cutler RG. 1984. Urate and ascorbate: Their possible roles as antioxidants in determining longevity of mammalian species. Arch Gerontol Geriatr 3: 321-348.
14. Danielson C, Houseworth J, Skipworth E, Smith D, McCarthy L, Nanagas K. 2006. Arsine toxicity treated with red blood cell and plasma exchanges. Transfusion 46: 1576-1579.
15. Davila JC, Davis PJ, Acosta D. 1991. Changes in glutathione and cellular energy as potential mechanisms of papaverine-induced hepatotoxicity in vitro. Toxicol Appl Pharmacol 108: 28-36.
16. Díaz-Villaseñor A, Burns AL, Hiriart M, Cebrián ME, Ostrosky-Wegman P. 2007. Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus. Toxicol Appl Pharmacol 225: 123-133.
17. Doumas BT, Watson WA, Biggs HG. 1971. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31: 87-96.
18. Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77.
19. Eyer P, Worek F, Kiderlen D, Sinko G, Stuglin A, Simeon-Rudolf V, Reiner E. 2003. Molar absorption coefficients for the reduced Ellman reagent: Reassessment. Anal Biochem 312: 224-227.
20. Fatmi Z, Azam I, Ahmed F, Kazi A, Gill AB, Kadir MM, Ahmed M, Ara N, Janjua NZ.Core Group for Arsenic Mitigation in Pakistan. 2009. Health burden of skin lesions at low arsenic exposure through groundwater in Pakistan. Is river the source? Environ Res 109: 575-581.
21. Fisher R A, Yates R. 1974. Statistical tables for biological, agricultural and medical research. London: Longman Group.
22. Fossati P, Prencipe L, Berti G. 1980. Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4- aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 26: 227-231.
23. Fossati P, Ponti M, Prencipe L, Tarenghi G. 1989. One-step protocol for assays of total and direct bilirubin with stable combined reagents. Clin Chem 35: 173-176.
24. Gailer J. 2009. Chronic toxicity of As(III) in mammals: the role of (GS)(2)AsSe(-). Biochimie 91: 1268-1272.
25. Garcia-Martinez V, Macias D, Gañan Y, Garcia-Lobo JM, Francia MV, Fernandez-Teran MA, Hurle JM. 1993. Internucleosomal DNA fragmentation and programmed cell death (apoptosis) in the interdigital tissue of the embryonic chick leg bud. J Cell Sci 106: 201-208.
26. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. 2005. Uric acid and oxidative stress. Curr Pharm Des 11: 4145-4151.
27. Gurr JR, Liu F, Lynn S, Jan KY. 1998. Calcium-dependent nitric oxide production is involved in arsenite-induced micronuclei. Mutat Res 416: 137-148.
28. Hernández-Zavala A, Del Razo LM, Aguilar C, García-Vargas GG, Borja VH, Cebrián ME. 1998. Alteration in bilirubin excretion in individuals chronically exposed to arsenic in Mexico. Toxicol Lett 99: 79-84.
29. Hogan GR. 1985. Neutrophilic granulocytosis following lead acetate in female mice. Experientia 41: 942-943.
30. Jauge P, Del-Razo LM. 1985. Uric acid levels in plasma and urine in rats chronically exposed to inorganic As (III) and As(V). Toxicol Lett 26: 31-35.
31. Keay G, Doxey DL. 1984. A study of the interaction between bromocresol green dye and bovine, ovine and equine serum globulins. Vet Res Commun 8: 25-32.
32. Kligerman AD, Tennant AH. 2007. Insights into the carcinogenic mode of action of arsenic. Toxicol Appl Pharmacol 222: 281-288.
33. Liu J, Waalkes MP. 2008. Liver is a target of arsenic carcinogenesis. Toxicol Sci 105: 24-32.
34. Liva SM, Voskuhl RR. 2001. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 167: 2060-2067.
35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
36. Maiti S, Chatterjee AK. 2000. Differential response of cellular antioxidant mechanism of liver and kidney to arsenic exposure and its relation to dietary protein deficiency. Environ Toxicol Pharmacol 8: 227-235.
37. Maiti S, Chatterjee AK. 2001. Effects on levels of glutathione and some related enzymes in tissues after an acute arsenic exposure in rats and their relationship to dietary protein deficiency. Arch Toxicol 75: 531-537.
38. Maiti S, Grant S, Baker SM, Karanth S, Pope CN, Chen G. 2004. Stress regulation of sulfotransferases in male rat liver. Biochem Biophys Res Commun 323: 235-241.
39. Maiti S, Zhang J, Chen G. 2007. Redox regulation of human estrogen sulfotransferase (hSULT1E1). Biochem Pharmacol 73: 1474-1481.
40. Marklund S. 1976. Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase. J Biol Chem 251: 7504-7507.
41. Miao G. 2002. Reference values of erythrocyte sedimentation rate of adult healthy subjects. Arch Med Res 33: 506-509.
42. Molloy EJ, O'Neill AJ, Grantham JJ, Sheridan-Pereira M, Fitzpatrick JM, Webb DW, Watson RW. 2003. Sex-specific alterations in neutrophil apoptosis: The role of estradiol and progesterone. Blood 102: 2653-2659.
43. Nag JK, Balaram V, Rubio R, Albertí J, Das AK. 1996. Inorganic arsenic species in groundwater: A case study from Purbasthali (Burdwan), India. J Trace Elem Med Biol 10: 20-24.
44. Naranmandura H, Suzuki KT. 2008. Formation of dimethylthioarsenicals in red blood cells. Toxicol Appl Pharmacol 227: 390-399.
45. Naranmandura H, Suzuki N, Takano J, McKnight-Whitford T, Ogra Y, Suzuki KT, Le XC. 2009. Systemic distribution and speciation of diphenylarsinic acid fed to rats. Toxicol Appl Pharmacol 237: 214-220.
46. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. 1997. Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin Chem 43: 1209-1214.
47. Pardue HL, Bacon BL, Nevius MG, Skoug JW. 1987. Kinetic study of the Jaffé reaction for quantifying creatinine in serum: 1. Alkalinity controlled with NaOH. Clin Chem 33: 278-285.
48. Rahman MM, Sengupta MK, Ahamed S, Chowdhury UK, Lodh D, Hossain A, Das B, Roy N, Saha KC, Palit SK, Chakraborti D. 2005. Arsenic contamination of groundwater and its health impact on residents in a village in West Bengal, India. Bull World Health Organ 83: 49-57.
49. Rahman MM, Ng JC, Naidu R. 2009. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ Geochem Health 31: 189-200.
50. Ranganathan H, Gunasekaran N. 2006. Simple method for estimation of hemoglobin in human blood using color analysis. IEEE Trans Inf Technol Biomed 10: 657-662.
51. Rhee SG. 1999. Redox signaling: Hydrogen peroxide as intracellular messenger. Exp Mol Med 31: 53-59.
52. Rothenberg ME, Hogan SP. 2006. The eosinophil. Annu Rev Immunol 24: 147-174.
53. Roychowdhury T, Tokunaga H, Ando M. 2003. Survey of arsenic and other heavy metals in food composites and drinking water and estimation of dietary intake by the villagers from an arsenic-affected area of West Bengal, India. Sci Total Environ 308: 15-35.
54. Santra A, Maiti A, Das S, Lahiri S, Charkaborty SK, Mazumder DN. 2000. Hepatic damage caused by chronic arsenic toxicity in experimental animals. J Toxicol Clin Toxicol 38: 395-405.
55. Schumann G, Bonora R, Ceriotti F, Férard G, Ferrero CA, Franck PF, Gella FJ, Hoelzel W, Jørgensen PJ, Kanno T, Kessner A, Klauke R, Kristiansen N, Lessinger JM, Linsinger TP, Misaki H, Panteghini M, Pauwels J, Schiele F, Schimmel HG, Weidemann G, Siekmann L; International Federation of Clinical Chemistry and Laboratory Medicine. 2002. International Federation of Clinical Chemistry and Laboratory Medicine. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. Clin Chem Lab Med 40: 718-724.
56. Schumann G, Bonora R, Ceriotti F, Férard G, Ferrero CA, Franck PF, Gella FJ, Hoelzel W, Jørgensen PJ, Kanno T, Kessner A, Klauke R, Kristiansen N, Lessinger JM, Linsinger TP, Misaki H, Panteghini M, Pauwels J, Schiele F, Schimmel HG, Weidemann G, Siekmann L; International Federation of Clinical Chemistry and Laboratory Medicine. 2002. International Federation of Clinical Chemistry and Laboratory Medicine. IFCC primary eference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 6. Reference procedure for the measurement of catalytic concentration of gamma-glutamyltransferase. Clin Chem Lab Med 40: 734-738.
57. Shi HZ. 2004. Eosinophils function as antigen-presenting cells. 2004. J Leukoc Biol 76: 520-527.
58. Simmons D, Williams DR. 1994. Random blood glucose as a screening test for diabetes in a biethnic population. Diabet Med 11: 830-835.
59. Toncev G. 2006. Therapeutic value of serum uric acid levels increasing in the treatment of multiple sclerosis. Vojnosanit Pregl 63: 879-882.
60. Tseng CH. 2009. A review on environmental factors regulating arsenic methylation in humans. Toxicol Appl Pharmacol 235: 338-350.
61. Vermeulen K, Van Bockstaele DR, Berneman ZN. 2005. Apoptosis: mechanisms and relevance in cancer. Ann Hematol 84: 627-639.
62. Wu MM, Chiou HY, Wang TW, Hsueh YM, Wang IH, Chen CJ, Lee TC. 2001. Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ Health Perspect 109: 1011-1017.
63. Wyllie AH. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556.
64. Xue DB, Zhang WH, Yun XG, Song C, Zheng B, Shi XY, Wang HY. 2007. Regulating effects of arsenic trioxide on cell death pathways and inflammatory reactions of pancreatic acinar cells in rats. Chin Med J (Engl) 20: 690-695.
65. Yadav JK, Prakash V. 2009. Thermal stability of alpha-amylase in aqueous cosolvent systems. J Biosci 34: 377-387.
66. Yáñez L, García-Nieto E, Rojas E, Carrizales L, Mejía J, Calderón J, Razo I, Díaz-Barriga F. 2003. DNA damage in blood cells from children exposed to arsenic and lead in a mining area. Environ Res 93: 231-240.
67. Zhang TC, Schmitt MT, Mumford JL. 2003. Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro. Carcinogenesis 24: 1811-1817.